» Articles » PMID: 24711916

Serum Thrombopoietin and CMpl Expression in Thrombocytopenia of Different Etiologies

Overview
Journal Hematol Rep
Publisher MDPI
Date 2014 Apr 9
PMID 24711916
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between thrombopoietin (TPO) and its receptor cMpl in thrombocytopenic conditions has not been entirely clarified. To elucidate this interplay may expand the spectrum of indications of TPO mimetics. In this study we have explored the relationship between TPO and cMpl in platelets and megakaryocytes of 43 patients with thrombocytopenia due to idiopathic thrombocytopenic purpura (ITP), bone marrow hypoplasia, myelodysplastic syndromes (MDS), and familial thrombocytopenia. Data were compared to cMpl and TPO in patients with a normal platelet count and in patients with thrombocytosis due to essential thrombocythemia (ET). All but familial patients showed higher TPO compared to controls. All thrombocytopenic states were invariably associated with increased expression of platelet cMPL compared to healthy controls. ET patients showed normal TPO and a trend toward a reduced cMpl expression. Immunofluorescence of bone marrow sections from patients with ITP and MDS failed to show a peculiar pattern compared to controls. Multiple mechanisms regulate TPO and cMpl in thrombocytopenic conditions.

Citing Articles

Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.

Kashiwagi H, Kuwana M, Murata M, Shimada N, Takafuta T, Yamanouchi J Int J Hematol. 2023; 119(1):1-13.

PMID: 37957517 PMC: 10770234. DOI: 10.1007/s12185-023-03672-1.


Evaluating the Role of Janus Kinase Pathways in Platelet Homeostasis Using a Systems Modeling Approach.

Koride S, Nayak S, Banfield C, Peterson M CPT Pharmacometrics Syst Pharmacol. 2019; 8(7):478-488.

PMID: 31044523 PMC: 6656939. DOI: 10.1002/psp4.12419.


Icaritin Provokes Serum Thrombopoietin and Downregulates Thrombopoietin/MPL of the Bone Marrow in a Mouse Model of Immune Thrombocytopenia.

Zhang K, Dai Z, Liu R, Tian F, Liu X, Sun Y Mediators Inflamm. 2018; 2018:7235639.

PMID: 30224899 PMC: 6129856. DOI: 10.1155/2018/7235639.


[Clinical analysis of recombinant human thrombopoietin for 92 adults with severe primary immune thrombocytopenia].

Liu X, Huang Y, Liu W, Chen Y, Xue F, Zhang L Zhonghua Xue Ye Xue Za Zhi. 2015; 36(4):312-5.

PMID: 25916293 PMC: 7342612. DOI: 10.3760/cma.j.issn.0253-2727.2015.04.011.

References
1.
Dahlen D, Broudy V, Drachman J . Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs. Blood. 2003; 102(1):102-8. DOI: 10.1182/blood-2002-11-3468. View

2.
Potapova T, Sivakumar S, Flynn J, Li R, Gorbsky G . Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibited. Mol Biol Cell. 2011; 22(8):1191-206. PMC: 3078080. DOI: 10.1091/mbc.E10-07-0599. View

3.
Yoon S, Li C, Tefferi A . Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: immunoperoxidase staining patterns and clinical correlates. Eur J Haematol. 2000; 65(3):170-4. DOI: 10.1034/j.1600-0609.2000.90235.x. View

4.
Houwerzijl E, Blom N, van der Want J, Esselink M, Koornstra J, Smit J . Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood. 2003; 103(2):500-6. DOI: 10.1182/blood-2003-01-0275. View

5.
Kaushansky K . The molecular mechanisms that control thrombopoiesis. J Clin Invest. 2005; 115(12):3339-47. PMC: 1297257. DOI: 10.1172/JCI26674. View